These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 35588085)

  • 1. Clinical presentation and outcome of human papillomavirus-positive nasopharyngeal carcinoma in a North American cohort.
    Huang SH; Jacinto JCK; O'Sullivan B; Su J; Kim J; Ringash J; Spreafico A; Yu E; Perez-Ordonez B; Weinreb I; Cho J; Hope AJ; Bratman SV; Giuliani ME; Hosni A; Hahn E; Goldstein DP; Tong L; Eng L; Xu W; Waldron JN
    Cancer; 2022 Aug; 128(15):2908-2921. PubMed ID: 35588085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasopharyngeal cancer: Incidence and prognosis of human papillomavirus and Epstein-Barr virus association at a single North American institution.
    Wu SS; Chen B; Fleming CW; Shah AA; Griffith CC; Domb C; Reddy CA; Campbell SR; Woody NM; Lamarre ED; Lorenz RR; Prendes BL; Scharpf J; Schwartzman L; Geiger JL; Koyfman SA; Ku JA
    Head Neck; 2022 Apr; 44(4):851-861. PubMed ID: 35040516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of human papillomavirus on nasopharyngeal carcinoma in Japan.
    Kano M; Kondo S; Wakisaka N; Moriyama-Kita M; Nakanishi Y; Endo K; Murono S; Nakamura H; Yoshizaki T
    Auris Nasus Larynx; 2017 Jun; 44(3):327-332. PubMed ID: 27499435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus may be common within nasopharyngeal carcinoma of Caucasian Americans: investigation of Epstein-Barr virus and human papillomavirus in eastern and western nasopharyngeal carcinoma using ligation-dependent polymerase chain reaction.
    Punwaney R; Brandwein MS; Zhang DY; Urken ML; Cheng R; Park CS; Li HB; Li X
    Head Neck; 1999 Jan; 21(1):21-9. PubMed ID: 9890347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of human papillomavirus and Epstein-Bar virus in nasopharyngeal carcinoma.
    Verma N; Patel S; Osborn V; McBride S; Riaz N; Lee A; Katabi N; Sherman E; Lee NY; Tsai CJ
    Head Neck; 2020 Sep; 42(9):2364-2374. PubMed ID: 32415906
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epstein-Barr virus and human papillomavirus serum antibodies define the viral status of nasopharyngeal carcinoma in a low endemic country.
    Simon J; Schroeder L; Ingarfield K; Diehl S; Werner J; Brenner N; Liu Z; Pawlita M; Pring M; Butt J; Ness A; Waterboer T
    Int J Cancer; 2020 Jul; 147(2):461-471. PubMed ID: 32279316
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonendemic HPV-positive nasopharyngeal carcinoma: association with poor prognosis.
    Stenmark MH; McHugh JB; Schipper M; Walline HM; Komarck C; Feng FY; Worden FP; Wolf GT; Chepeha DB; Prince ME; Bradford CR; Mukherji SK; Eisbruch A; Carey TE
    Int J Radiat Oncol Biol Phys; 2014 Mar; 88(3):580-8. PubMed ID: 24521676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a low-incidence population.
    Dogan S; Hedberg ML; Ferris RL; Rath TJ; Assaad AM; Chiosea SI
    Head Neck; 2014 Apr; 36(4):511-6. PubMed ID: 23780921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human papillomavirus and Epstein-Barr virus in nasopharyngeal carcinoma in a non-endemic eastern european population.
    Svajdler M; Kaspirkova J; Mezencev R; Laco J; Torday T; Dubinsky P; Straka L; Ondic O; Michal M; Skalova A
    Neoplasma; 2016; 63(1):107-14. PubMed ID: 26639240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics and prognostic value of pre-retreatment plasma epstein-barr virus DNA in locoregional recurrent nasopharyngeal carcinoma.
    Liu MZ; Fang SG; Huang W; Wang HY; Tian YM; Huang RD; Sun Z; Zhao C; Lu TX; Huang Y; Han F
    Cancer Med; 2019 Aug; 8(10):4633-4643. PubMed ID: 31268626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus and human papillomaviruses as favorable prognostic factors in nasopharyngeal carcinoma: A nationwide study in Finland.
    Ruuskanen M; Irjala H; Minn H; Vahlberg T; Randen-Brady R; Hagström J; Syrjänen S; Leivo I
    Head Neck; 2019 Feb; 41(2):349-357. PubMed ID: 30549170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HPV-positive/p16-positive/EBV-negative nasopharyngeal carcinoma in white North Americans.
    Maxwell JH; Kumar B; Feng FY; McHugh JB; Cordell KG; Eisbruch A; Worden FP; Wolf GT; Prince ME; Moyer JS; Teknos TN; Chepeha DB; Stoerker J; Walline H; Carey TE; Bradford CR
    Head Neck; 2010 May; 32(5):562-7. PubMed ID: 19757421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of Epstein-Barr virus and human papillomavirus infection on macrophage migration inhibitory factor and macrophage polarization in nasopharyngeal carcinoma.
    Feng G; Xu Y; Ma N; Midorikawa K; Oikawa S; Kobayashi H; Nakamura S; Ishinaga H; Zhang Z; Huang G; Takeuchi K; Murata M
    BMC Cancer; 2021 Aug; 21(1):929. PubMed ID: 34407796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Viral markers in nasopharyngeal carcinoma: A systematic review and meta-analysis on the detection of p16
    Tham T; Machado R; Russo DP; Herman SW; Teegala S; Costantino P
    Am J Otolaryngol; 2021; 42(1):102762. PubMed ID: 33202328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epstein-Barr virus and human papillomavirus infections and genotype distribution in head and neck cancers.
    Deng Z; Uehara T; Maeda H; Hasegawa M; Matayoshi S; Kiyuna A; Agena S; Pan X; Zhang C; Yamashita Y; Xie M; Suzuki M
    PLoS One; 2014; 9(11):e113702. PubMed ID: 25405488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic values of the integrated model incorporating the volume of metastatic regional cervical lymph node and pretreatment serum Epstein-Barr virus DNA copy number in predicting distant metastasis in patients with N1 nasopharyngeal carcinoma.
    Yao JJ; Zhou GQ; Wang YQ; Wang SY; Zhang WJ; Jin YN; Zhang F; Li L; Liu LZ; Cheng ZB; Ma J; Qi ZY; Sun Y
    Chin J Cancer; 2017 Dec; 36(1):98. PubMed ID: 29284539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The diagnostic and prognostic values of plasma Epstein-Barr virus DNA for residual cervical lymphadenopathy in nasopharyngeal carcinoma patients: a retrospective study.
    Liu SL; Sun XS; Li XY; Tang LQ; Chen QY; Lin HX; Liang YJ; Yan JJ; Lin C; Guo SS; Liu LT; Li Y; Xie HJ; Tang QN; Liang H; Guo L; Mai HQ
    Cancer Commun (Lond); 2019 Mar; 39(1):14. PubMed ID: 30925939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proposed modifications and incorporation of plasma Epstein-Barr virus DNA improve the TNM staging system for Epstein-Barr virus-related nasopharyngeal carcinoma.
    Guo R; Tang LL; Mao YP; Du XJ; Chen L; Zhang ZC; Liu LZ; Tian L; Luo XT; Xie YB; Ren J; Sun Y; Ma J
    Cancer; 2019 Jan; 125(1):79-89. PubMed ID: 30351466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retrospective analysis of oncogenic human papilloma virus and Epstein-Barr virus prevalence in Turkish nasopharyngeal cancer patients.
    Tatlı Doğan H; Kılıçarslan A; Doğan M; Süngü N; Güler Tezel G; Güler G
    Pathol Res Pract; 2016 Nov; 212(11):1021-1026. PubMed ID: 27640103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of plasma Epstein-Barr virus DNA level during posttreatment follow-up in the patients with nasopharyngeal carcinoma having undergone intensity-modulated radiotherapy.
    Li WF; Zhang Y; Huang XB; Du XJ; Tang LL; Chen L; Peng H; Guo R; Sun Y; Ma J
    Chin J Cancer; 2017 Nov; 36(1):87. PubMed ID: 29116021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.